Heimdall Insights

Global Hurler Syndrome Market

Sizing, Segmentation, & Growth Forecast (2025-2030)

Last updated: August 2026

Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.

Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).

1. Summary

The Global Hurler Syndrome Market was valued at $680 mn. in 2025. During the forecast period 2025-2030, it is expected to grow at 8.5% CAGR, to an estimated market size of $1.0 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The Global Hurler Syndrome Market encompasses therapeutic interventions for Mucopolysaccharidosis Type I (MPS I), a rare autosomal recessive lysosomal storage disorder caused by a deficiency of the alpha-L-iduronidase enzyme. The scope includes Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplantation (HSCT), and emerging gene therapies, while excluding general supportive care and non-specific surgical interventions.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Hurler Syndrome Market in the period 2025-30:

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:

Geographies

  • North America
  • Europe
  • Asia-Pacific
  • Rest of World

Segments

  • Enzyme Replacement Therapy (ERT)
  • Hematopoietic Stem Cell Transplantation (HSCT)
  • Gene & Emerging Therapies